MetaCap

Neuphoria Therapeutics Statistics

NASDAQ: NEUPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.35+0.03 (+1.29%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Neuphoria Therapeutics by the numbers

Neuphoria Therapeutics has a market capitalization of $12.7 million based on 5.41M shares outstanding. With trailing EPS of $-2.07, Neuphoria Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 27.2% below its 50-day average and 42.1% below its 200-day average.

Average daily trading volume is 26.53K shares, or about $62,336 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

NEUP valuation vs. peer median

NEUP compared with the median of 8 peer companies
MetricNEUPPeer medianDifference
Market cap$12.72M$13.01M-2%
Avg. volume26.53K259.61K-90%

Peer median across 8 companies: ALLR, MCRB, MIRA, BOLT, TVRD, ACTU, BYSI, CTXR.

Valuation

Market cap
$12.72M
Price / sales (latest FY)
10.83
EPS (TTM)
$-2.07

Price and trading

Previous close
2.32
Open
2.33
Day range
2.27 – 2.38
52-week range
2.26 – 5.53
52-week change
-47.31%
Beta
—
Volume
55.96K

Dividends and events

Annual dividend
None
Next earnings date
Mar 13, 2025

Additional statistics

Market Cap
12.72M
Forward Pe
-0.96
Eps
-2.07
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
5.53
Week52 Low
2.26
Avg Volume
26,526.00
Shares Outstanding
5.41M
Ma50
3.23
Ma200
4.06
Earnings Date
Mar 13, 2025
Pct From52w High
-57.50%
Pct From52w Low
3.98%

Related